This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Shared genetic risk loci between Alzheimer’s disease and related dementias, Parkinson’s disease, and amyotrophic lateral sclerosis
Alzheimer's Research & Therapy Open Access 16 June 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Hinderer, C. et al. Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations. Ann. Clin. Transl Neurol. https://doi.org/10.1002/acn3.51165 (2020)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fyfe, I. Potential gene therapy for FTD. Nat Rev Neurol 16, 600 (2020). https://doi.org/10.1038/s41582-020-00423-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41582-020-00423-2
This article is cited by
-
Shared genetic risk loci between Alzheimer’s disease and related dementias, Parkinson’s disease, and amyotrophic lateral sclerosis
Alzheimer's Research & Therapy (2023)